Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
NAD+/NADH Homeostasis in Fungal Hypoxia
2026-09-07
This award review explains how oxygen limitation reshapes filamentous-fungal metabolism through changes in the NAD+/NADH balance. Its key contribution is linking redox control not only to fermentation, respiration, and growth, but also to secondary-metabolite production through NAD+-dependent regulation of sirtuin A and Nudix hydrolase A.
-
Protoporphyrin IX at the Iron–Light Interface
2026-09-05
Protoporphyrin IX is a photodynamic compound that connects heme formation, light-driven biology, and iron-dependent cancer research. This article explains how to distinguish photodynamic effects from ferroptosis mechanisms and design more interpretable assays.
-
U-73122: Phospholipase C Inhibitor Workflows
2026-09-04
U-73122 provides a practical way to interrogate PLC-dependent calcium flux, chemotaxis, inflammation, and cancer-cell invasion. This guide translates its reported activity into controlled assay workflows, quantitative starting conditions, and troubleshooting decisions for reproducible PLC signaling pathway modulation.
-
Caspase-8 Fluorometric Assay Kit: Signal to Insight
2026-09-04
The Caspase-8 Fluorometric Assay Kit converts IETD-dependent cleavage into a quantitative readout for apoptosis and inflammatory cell-death research. This guide focuses on interpreting caspase-8 activity as causal evidence, using combination-therapy findings to design stronger, orthogonally validated experiments.
-
RHEB Neddylation Links UBE2F to Liver Tumorigenesis
2026-09-03
The reference study identifies RHEB as a non-cullin substrate of the UBE2F–SAG neddylation axis and shows that modification at K169 strengthens lysosomal localization, GTP binding, and mTORC1 activation. Cellular, genetic mouse, and patient-correlation data connect this mechanism to hepatic steatosis, hepatocellular carcinoma biology, and survival, while also defining important limits for therapeutic translation.
-
c-Myc Peptide: From Assay Control to Translation
2026-09-03
A strategic guide to using the c-Myc tag Peptide as a sequence-defined displacement reagent, while connecting immunoassay rigor with broader questions about transcription factor stability, signaling, and translational reproducibility.
-
Z-VDVAD-FMK in Apoptosis Workflow Design
2026-09-02
Z-VDVAD-FMK helps researchers separate caspase-2-centered apoptosis from caspase-independent death and caspase-1-driven pyroptosis. This practical guide covers mitochondrial cytochrome c release inhibition, dose-planning, orthogonal readouts, and troubleshooting for cancer research models.
-
Plerixafor (AMD3100) in CXCR4 Research
2026-09-02
Plerixafor (AMD3100) provides a reversible way to interrogate CXCL12/CXCR4 signaling in tumor trafficking, stem cell retention, and inflammatory cell movement. This workflow-focused guide connects assay design, dose selection, sample handling, and troubleshooting to practical cancer and hematology research use cases.
-
MK-1775: Reading Wee1 Inhibition in Cancer Cells
2026-09-01
MK-1775 is a Wee1 kinase inhibitor whose effects are best understood through time-resolved measurements of checkpoint override, proliferation, and cell death. This article translates mechanistic biology and Schwartz’s viability framework into a practical assay strategy for studying DNA damage response inhibition in p53-deficient tumor models.
-
Gramine–CUL3–MTDH Ferroptosis in TNBC
2026-09-01
The reference study identifies Gramine, also known as 1-(1H-indol-3-yl)-N,N-dimethylmethanamine, as a selective ferroptosis inducer in triple-negative breast cancer through the CUL3–MTDH ubiquitination axis. Its combination of target-engagement assays, ferroptosis rescue experiments, genetic perturbation, and xenograft validation provides a mechanism-focused framework for TNBC and cancer biology research.
-
Benzyl Quinolone Carboxylic Acid (BQCA) Workflows
2026-08-31
Benzyl Quinolone Carboxylic Acid (BQCA) enables controlled potentiation of M1 signaling instead of relying only on maximal orthosteric stimulation. This practical guide connects BQCA dose–response, BRET-based protein-interaction assays, neuronal activity readouts, and troubleshooting strategies for Alzheimer’s disease research and cognitive function modulation.
-
CA800-PR Targets PGR in HR+ Breast Cancer
2026-08-31
The reference study introduces CA800-PR, a tumor-targeted heptamethine cyanine dye that combines near-infrared imaging with direct antitumor activity in hormone receptor-positive breast cancer. In MCF-7 models, the dye induced Golgi fragmentation, selectively reduced progesterone receptor protein, promoted apoptosis, and was associated with a pro-inflammatory antitumor immune response.
-
Dual-Action Podophyllotoxin Derivative 5p
2026-08-30
The reference study shows that podophyllotoxin derivative 5p combines topoisomerase IIα catalytic inhibition with suppression of microtubule polymerization, producing activity in several multidrug-resistant cancer models. Its effects on drug-efflux proteins, G2/M arrest, apoptosis, pyroptosis-associated markers, and xenograft growth support a dual-mechanism strategy for anticancer drug research, while also highlighting the need for further pharmacological validation.
-
Metronidazole: Designing Causal Transporter Assays
2026-08-29
Metronidazole is more than a nitroimidazole antibiotic: its OAT3 inhibition creates a controlled way to study drug uptake and drug-drug interaction modulation. This article presents a causal assay framework that separates transporter effects from microbiota-associated immune changes.
-
CFDA-SE Workflows for Proliferation Tracking
2026-08-28
CFDA-SE converts intracellular esterase activity into a division-sensitive fluorescence record for viable cells, supporting lymphocyte, fibroblast, NK-cell, and bacterial studies. This guide shows how to pair proliferation history with migration and CD38 surface-proximity experiments without confusing a phenotypic readout with a molecular interaction map.